Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

PharmEnable Therapeutics is a biopharmaceutical company focused on reimagining small molecule therapeutics through AI. They aim to develop life-changing medicines for cancer and neurological diseases…

PharmEnable Therapeutics is a biopharmaceutical company focused on reimagining small molecule therapeutics through AI. They aim to develop life-changing medicines for cancer and neurological diseases…
What they do: AI-enabled small-molecule drug discovery targeting previously inaccessible chemical space
Therapeutic focus: Cancer and neurological diseases
Proprietary tech: chemSEEK AI-enabled drug discovery platform
Founded: 2016
Latest disclosed financing: $7.5M Pre-Series A (May 2023)
Discovery of small-molecule drugs for challenging biological targets (e.g., GPCRs, neurodegeneration targets) by expanding accessible chemical space.
2016
Biotechnology
£1.8M
Seed financing to support transition into drug development
$7.5M
Included participation from existing investors such as Cambridge Enterprise and Parkwalk Advisors
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
4,500+
New This Week